EDGAR Filing Documents for 0001193125-13-067169

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-13-067169

Filing Date

2013-02-20

Accepted

2013-02-20 16:01:05

Documents

Period of Report

2012-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d452997d10k.htm	10-K	1169780
2	EX-10.23	d452997dex1023.htm	EX-10.23	59381
3	EX-23.1	d452997dex231.htm	EX-23.1	1564
4	EX-31.1	d452997dex311.htm	EX-31.1	9428
5	EX-31.2	d452997dex312.htm	EX-31.2	9426
6	EX-32.1	d452997dex321.htm	EX-32.1	3094
7	EX-32.2	d452997dex322.htm	EX-32.2	3209
14	GRAPHIC	g452997g71f41.jpg	GRAPHIC	73720
	Complete submission text file	0001193125-13-067169.txt		6788185

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	achn-20121231.xml	EX-101.INS	868412
9	XBRL TAXONOMY EXTENSION SCHEMA	achn-20121231.xsd	EX-101.SCH	74524
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	achn-20121231_cal.xml	EX-101.CAL	69382
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	achn-20121231_def.xml	EX-101.DEF	362741
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE	achn-20121231_lab.xml	EX-101.LAB	518210
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	achn-20121231_pre.xml	EX-101.PRE	424231

Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511

Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000

ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)